10 Most Oversold S&P 500 Stocks So Far in 2025
The S&P 500 Index has delivered a strong performance in 2025 as it has climbed over 7% and reached new all-time highs.
Posts Tagged ‘NYSE:WST’
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on WST.
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market?
Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services (WST) Fell on Lowered Guidance
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter.
Should You Hold West Pharmaceutical Services (WST)?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Swiss Transparent Portfolio’s Substack.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Business Model Mastery’s Substack.
West Pharmaceutical Services (WST) Fell on Disappointing Guidance
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why West Pharmaceutical Services (WST) Stock Fell 38%
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties...
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript April 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
15 Low Profile Dividend Champions to Buy
Companies known as Dividend Aristocrats belong to the S&P Index and have raised their dividend payments every year for a minimum of 25 years.
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript February 13, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services (WST) Bounced Back in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.
Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
Here’s Why West Pharmaceutical Services (WST) Bounced Back in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.56, expectations were $1.26. West Pharmaceutical Services, Inc.
What Makes West Pharmaceutical Services (WST) an Attractive Bet?
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here...
5 Most Reliable Dividend Stocks To Buy
In this article, we discuss 5 most reliable dividend stocks to buy.
West Pharmaceutical Services (WST) Fell on Reduced Full Year Guidance
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.83, expectations were $1.78. West Pharmaceutical Services, Inc.
Ken Griffin’s Wellington Fund Delivers Mind-Numbing Returns: Here are Its Top 15 Stocks
In this article, we will explore Ken Griffin's Wellington Fund delivers mind-numbing returns and its top 15 stocks.
Here’s Why West Pharmaceutical Services (WST) Fell in Q4
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
13 Best Dividend Stocks with Upside Potential
In this article, we discuss 13 best dividend stocks with upside potential.
5 Best Performing Dividend Stocks in 2023
In this article, we discuss 5 best-performing dividend stocks in 2023.
11 Best November Dividend Stocks To Buy
In this article, we discuss 11 best November dividend stocks to buy.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2023 West Pharmaceutical Services Earnings Conference Call.
10 Best Dividend Aristocrats According to Analysts
In this article, we discuss best dividend aristocrats according to analysts.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the DTE Energy Second Quarter 2023 Earnings Conference Call.
Should You Hold West Pharmaceutical Services (WST) for the Long-Term?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Top 20 Countries With Highest Drug Consumption
In this piece, we will take a look at the top 20 countries with the highest drug consumption.
25 S&P 500 Dividend Aristocrats To Avoid
In this article, we discuss 25 dividend aristocrats to avoid according to hedge funds.
West Pharmaceutical Services (WST) Beat Revenue Expectations
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2023 Earnings Call Transcript
Quintin Lai: …conference call.
What Makes West Pharmaceutical Services (WST) an Attractive Investment?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Dividend Stocks of 2023
In this article, we discuss 5 best dividend stocks of 2023.
Does West Pharmaceutical Services (WST) Have a Long Runway for Growth?
Baron Funds, an investment management company, released its “Baron Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call. .
5 Dividend Knights that Beat the Market Last 5 Years
In this article, we discuss 5 dividend stocks that beat the market last five years.
